vernomelitensin

from the leaves of Vernonia guineensis Benth. (Asteraceae); structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 03/27/2013 - "Vernopicrin (1) and Vernomelitensin (2) demonstrated in vitro activity against human cancer cell lines with IC50 ranging from 0.35-2.04μM (P<0.05) and 0.13-1.5μM (P<0.05), respectively, between the most and least sensitive cell lines for each compound. "
2.	Melanoma (Melanoma, Malignant) 03/27/2013 - "Vernopicrin was most active against the human melanoma (A375) cell line and least active against the lung cancer (A549) cell line, while Vernomelitensin was also most active against the human melanoma (A375) cell line and least active against the breast cancer (MCF-7) cell line. "
3.	Lung Neoplasms (Lung Cancer) 03/27/2013 - "Vernopicrin was most active against the human melanoma (A375) cell line and least active against the lung cancer (A549) cell line, while Vernomelitensin was also most active against the human melanoma (A375) cell line and least active against the breast cancer (MCF-7) cell line. "
4.	Breast Neoplasms (Breast Cancer) 03/27/2013 - "Vernopicrin was most active against the human melanoma (A375) cell line and least active against the lung cancer (A549) cell line, while Vernomelitensin was also most active against the human melanoma (A375) cell line and least active against the breast cancer (MCF-7) cell line. "

1.	vernopicrin